Dong‐Hua Luo

Combining pretreatment plasma Epstein‐Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study

Yu‐Yun Du, Dong‐Hua Luo, Lin‐Quan Tang et al. · Cancer Medicine · 2019 · 29 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Tislelizumab versus placebo combined with induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant tislelizumab or placebo for locoregionally advanced nasopharyngeal carcinoma: Interim analysis of a multicenter, randomized, placebo-controlled, double-blind, phase 3 trial.

Hai‐Qiang Mai, Sai Lan Liu, Qiu-Yan Chen et al. · Journal of Clinical Oncology · 2024 · 13 citations

Medicine, Oncology, Pharmacology +11

Neoadjuvant chemotherapy plus tislelizumab followed by concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial.

Qiuyan Chen, Hai‐Qiang Mai, Lin‐Quan Tang et al. · Journal of Clinical Oncology · 2022 · 12 citations

Medicine, Oncology, Pharmacology +17